{"id":"https://openalex.org/W3001737745","doi":"https://doi.org/10.1016/j.bbmt.2019.12.434","title":"Repeat Infusions of CD19 CAR-T Cells: Factors Associated with Response, CAR-T Cell In Vivo Expansion, and Progression-Free Survival","display_name":"Repeat Infusions of CD19 CAR-T Cells: Factors Associated with Response, CAR-T Cell In Vivo Expansion, and Progression-Free Survival","publication_year":2020,"publication_date":"2020-01-23","ids":{"openalex":"https://openalex.org/W3001737745","doi":"https://doi.org/10.1016/j.bbmt.2019.12.434","mag":"3001737745"},"language":"en","primary_location":{"id":"doi:10.1016/j.bbmt.2019.12.434","doi":"https://doi.org/10.1016/j.bbmt.2019.12.434","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bbmt.2019.12.434","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biology of Blood and Marrow Transplantation","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.bbmt.2019.12.434","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010158325","display_name":"Jordan Gauthier","orcid":"https://orcid.org/0000-0002-5769-8409","observed_orcids":["https://orcid.org/0000-0002-5769-8409"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jordan Gauthier","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036373597","display_name":"Evandro D. Bezerra","orcid":"https://orcid.org/0000-0002-8978-5697","observed_orcids":["https://orcid.org/0000-0002-8978-5697"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Evandro Dantas Bezerra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043131622","display_name":"Alexandre V. Vinaud Hirayama","orcid":"https://orcid.org/0000-0001-7980-3882","observed_orcids":["https://orcid.org/0000-0001-7980-3882"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexandre V. Hirayama","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109310755","display_name":"Barbara S. Pender","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Barbara S. Pender","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029498424","display_name":"Aesha Vakil","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aesha Vakil","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061167339","display_name":"Rachel N. Steinmetz","orcid":"https://orcid.org/0000-0001-8847-112X","observed_orcids":["https://orcid.org/0000-0001-8847-112X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachel N. Steinmetz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035086451","display_name":"Aude G. Chapuis","orcid":"https://orcid.org/0000-0002-9574-5448","observed_orcids":["https://orcid.org/0000-0002-9574-5448"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aude G. Chapuis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037938194","display_name":"Brian G. Till","orcid":"https://orcid.org/0000-0002-4718-8288","observed_orcids":["https://orcid.org/0000-0002-4718-8288"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian G. Till","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060993908","display_name":"Hans\u2010Peter Kiem","orcid":"https://orcid.org/0000-0001-5949-4947","observed_orcids":["https://orcid.org/0000-0001-5949-4947"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hans-Peter Kiem","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051296565","display_name":"Mazyar S. Shadman","orcid":"https://orcid.org/0000-0002-3365-6562","observed_orcids":["https://orcid.org/0000-0002-3365-6562"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mazyar Shadman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071844603","display_name":"Ryan Daniel Cassaday","orcid":"https://orcid.org/0000-0002-3424-2425","observed_orcids":["https://orcid.org/0000-0002-3424-2425"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryan D. Cassaday","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087281332","display_name":"Stanley R. Riddell","orcid":"https://orcid.org/0000-0002-4688-9920","observed_orcids":["https://orcid.org/0000-0002-4688-9920"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stanley R. Riddell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016684714","display_name":"David G. Maloney","orcid":"https://orcid.org/0000-0002-8477-6919","observed_orcids":["https://orcid.org/0000-0002-8477-6919"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David G. Maloney","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5089990813","display_name":"Cameron John Turtle","orcid":"https://orcid.org/0000-0002-4722-4461","observed_orcids":["https://orcid.org/0000-0002-4722-4461"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cameron J. Turtle","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3650,"currency":"USD","value_usd":3650},"apc_paid":{"value":3650,"currency":"USD","value_usd":3650},"fwci":0.2428,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.5173223,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"26","issue":"3","first_page":"S267","last_page":"S268"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd19-car-t-cells","display_name":"CD19 CAR T cells","score":0.9279999732971191},{"id":"https://openalex.org/keywords/relapsed-or-refractory-b-cell-malignancies","display_name":"relapsed or refractory B-cell malignancies","score":0.9700000286102295},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.8820000290870667},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":1.0},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8479999899864197},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6959999799728394},{"id":"https://openalex.org/keywords/lymphodepletion","display_name":"lymphocyte depletion","score":0.6769999861717224},{"id":"https://openalex.org/keywords/high-dose-chemotherapy","display_name":"high-dose chemotherapy","score":0.5180000066757202},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5830000042915344},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.3499999940395355},{"id":"https://openalex.org/keywords/bulky-disease","display_name":"bulky disease","score":0.4440000057220459}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9055285453796387},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.7272634506225586},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7138502597808838},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38193970918655396},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.35801607370376587},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.1458323895931244},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06250375509262085},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.042054057121276855}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.bbmt.2019.12.434","doi":"https://doi.org/10.1016/j.bbmt.2019.12.434","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bbmt.2019.12.434","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biology of Blood and Marrow Transplantation","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.bbmt.2019.12.434","doi":"https://doi.org/10.1016/j.bbmt.2019.12.434","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bbmt.2019.12.434","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biology of Blood and Marrow Transplantation","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.7799999713897705,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2748952813","https://openalex.org/W3031052312","https://openalex.org/W4389568370","https://openalex.org/W3032375762","https://openalex.org/W1995515455","https://openalex.org/W2080531066","https://openalex.org/W2586801360","https://openalex.org/W3108674512","https://openalex.org/W1506200166","https://openalex.org/W2604872355"],"abstract_inverted_index":{"Background":[0],"CD19-targeted":[2],"chimeric":[3],"antigen":[4],"receptor-engineered":[5],"(CD19":[6],"CAR)-T":[7],"cell":[8,58,104,296,324,362],"immunotherapy":[9],"has":[10],"shown":[11],"efficacy":[12],"for":[13,114,121,130,140],"relapsed":[14,179],"or":[15,25,180],"refractory":[16],"(R/R)":[17],"B-cell":[18,76],"malignancies,":[19],"but":[20],"absence":[21],"of":[22,34,46,83,210,218,231,310,343,367],"complete":[23],"response":[24,141,184,186,190,226,311],"relapses":[26],"are":[27],"still":[28],"observed":[29,204],"in":[30,59,144,199,208,252],"a":[31,80,89,241,316],"significant":[32],"portion":[33],"patients":[35],"(pts).":[36],"Objectives":[38],"To":[40],"evaluate":[41],"outcomes":[42],"after":[43,102,182,298,326,340],"repeat":[44],"infusion":[45,82,105],"CD19":[47,84,344],"CAR-T":[48,57,85,103,295,304,323,332,345,361],"cells,":[49],"and":[50,62,106,126,157,195,229,249,259,276,291,357],"identify":[51],"the":[52,110,127,245,292,360,365],"factors":[53],"associated":[54],"with":[55,74,350],"response,":[56],"vivo":[60],"expansion,":[61],"progression-free":[63],"survival":[64],"(PFS).":[65],"Methods":[67],"We":[69,203],"analyzed":[70],"data":[71],"from":[72],"pts":[73,138,159,170,213,221,234],"R/R":[75],"malignancies":[77],"who":[78],"received":[79],"second":[81,341],"cells":[86,346],"(CART2)":[87],"on":[88],"phase":[90],"1/2":[91],"trial":[92],"(NCT01865617)":[93],"at":[94,364],"our":[95],"institution.":[96],"Responses":[97],"were":[98,142,150,198,254],"evaluated":[99],"4":[100,217],"weeks":[101],"defined":[107],"according":[108],"to":[109,167,175,193,206,312,355],"2018":[111,119],"NCCN":[112],"guidelines":[113],"acute":[115],"lymphoblastic":[116],"leukemia":[117,124],"(ALL),":[118],"iwCLL":[120],"chronic":[122],"lymphocytic":[123],"(CLL),":[125],"Lugano":[128],"criteria":[129],"non-Hodgkin":[131],"lymphoma":[132],"(NHL).":[133],"Results":[135],"Forty-four":[137],"evaluable":[139],"included":[143],"this":[145],"study":[146],"(see":[147],"Table).":[148],"Pts":[149],"heavily":[151],"pre-treated":[152],"(median":[153],"prior":[154,354],"therapies,":[155],"6),":[156],"16":[158],"(36%)":[160],"had":[161,172],"bulky":[162],"(e":[163],"5cm)":[164],"disease.":[165],"Prior":[166],"CART2,":[168],"15":[169],"(32%)":[171],"not":[173],"responded":[174],"CART1,":[176,194],"22":[177],"(50%)":[178],"progressed":[181],"initial":[183],"(complete":[185],"[CR],":[187],"n=15;":[188],"partial":[189,225],"[PR],":[191,227],"n=7)":[192],"7":[196],"(16%)":[197],"ongoing":[200],"PR.":[201],"responses":[205],"CART2":[207,299,327],"3":[209],"14":[211],"ALL":[212],"(21%;":[214],"all":[215],"CR/CRi),":[216],"11":[219],"CLL":[220],"(36%;":[222],"CR/CRi,":[223],"n=3;":[224],"n=1),":[228],"9":[230],"19":[232],"NHL":[233],"(47%;":[235],"CR,":[236],"n=2;":[237],"PR,":[238],"n=7).":[239],"After":[240],"43-month":[242],"median":[243],"follow-up,":[244],"estimated":[246],"4-year":[247],"PFS":[248],"OS":[250],"probabilities":[251],"responders":[253],"23%":[255],"(95%":[256,261],"CI,":[257],"9-59%)":[258],"36%":[260],"CI":[262],"19-71%),":[263],"respectively.":[264],"Multivariable":[266],"logistic":[267],"regression":[268],"identified":[269],"lymphodepletion":[270,353],"intensity":[271,284,287],"before":[272],"CART1":[273,356],"(high-intensity":[274],"cyclophosphamide":[275],"fludarabine":[277],"[CyFlu]":[278],"vs":[279],"Other,":[280],"OR=12.19,":[281],"p=0.04;":[282],"high":[283],"versus":[285],"low":[286],"CyFlu,":[288],"OR=3.83,":[289],"p=0.08)":[290],"peak":[293,321],"blood":[294],"count":[297,325],"(OR=2.31":[300],"per":[301,329],"log10":[302,330],"CD8+":[303,322,331],"cell/\u00b5L":[305,333],"increase,":[306,334],"p=0.01)":[307],"as":[308],"predictors":[309],"CART2.":[313,368],"In":[315],"multivariable":[317],"Cox":[318],"model,":[319],"higher":[320],"(HR=0.47":[328],"p":[335],"Conclusion":[337],"Outcomes":[339],"infusions":[342],"might":[347],"be":[348],"improved":[349],"high-intensity":[351],"CyFlu":[352],"by":[358],"increasing":[359],"dose":[363],"time":[366]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2025-10-10T00:00:00"}